Daniel Benjamin

Daniel Benjamin is an experienced formulation scientist with a diverse background in the pharmaceutical industry. Currently serving as a Formulation Scientist at Supernus Pharmaceuticals, Inc. since July 2020, Daniel has previously held positions including Senior Scientist at AstraZeneca and Engineer II, Technology Transfer at Alkermes. With earlier roles as a Formulation Chemist at SUN PHARMA, Formulation Scientist at Catalent Pharma Solutions, and Associate Scientist at Novartis, Daniel has extensive expertise in product development, formulation, and process optimization, particularly in oral dosage forms. Daniel began a career in the industry as a Pilot Plant Engineer I at Sandoz, contributing to pilot scale production and troubleshooting processes. Academic credentials include a Master of Science in Pharmaceutical Engineering from New Jersey Institute of Technology and a Bachelor of Arts in Chemistry from Rutgers University–New Brunswick.